Condition: Shoulder Pain
Interventions: Drug: Liposomal Bupivacaine; Drug: 0.5% Bupivacaine HCL
Sponsor: New York University School of Medicine
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA)
May 5, 2019ClinicalTrials.govComments OffMusculoskeletalArthroplastyTSA | Block | Bupivacaine | EXPAREL | Interscalene | Liposomal | Nerve | Patients | Plus | Shoulder | Total | Undergoing | Versus
Comments
